Alembic Pharmaceuticals share price rose in the opening trade on September 15 following the company received establishment inspection report (EIR) post inspection by the US Food and Drug Administration (USFDA).At 09:20am, Alembic Pharmaceuticals was quoting at Rs 953.90, up Rs 8.10, or 0.86 percent, on the BSE.".... has EIR today for the inspection carried out conducted from 26th May, 2025 to 31st...

The shares of Waaree Energies fell over 2 percent on June 18, extending losses for a second day after a US Senate panel proposed to completely phase out solar and wind energy tax credits by 2028.Waaree Energies shares tracked its Wall Street peers that fell on the proposal, with First Solar shares down nearly 18 percent, while Solaredge Technologies fell as much as 33 percent. Shares of Sunrun- bi...

The benchmark indices corrected sharply after six consecutive days of gains, falling by 1 percent on June 12 due to profit booking. Market breadth was dominated by bears, with 1,945 shares declining versus 660 advancing shares on the NSE. The market may attempt a rebound amid likely range-bound trading in the upcoming session, but the sustainability is the key watch. Below are some short-term trad...

Alembic Pharma share price extended the gains on second day, rising 1 percent in the early trade on April 30 following Establishment Inspection Report (EIR) for its Panelav-based oncology formulation facility.At 09:20am, Alembic Pharmaceuticals was quoting at Rs 888.45, up Rs 9.20, or 1.05 percent, on the BSE.US Food and Drug Administration (USFDA) has carried out inspection at the said between fr...

Shares of Waaree Energies Ltd gained as much as 3 percent to Rs 2,648 in early trade on January 13 after the company announced its plans to acquire Enel Green Power India Private Ltd (EGPIPL) in a deal valued at up to Rs 792 crore, subject to customary adjustments. The company signed a share purchase agreement with Enel Green Power Development on Friday marking its strategic entry into the renewab...